1 Nuclear Medicine/Radiopharmaceuticals Market Overview 1.1 Nuclear Medicine/Radiopharmaceuticals Product Scope 1.2 Nuclear Medicine/Radiopharmaceuticals Segment by Type 1.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2020-2026) 1.2.2 Diagnostic 1.2.3 Therapeutic 1.3 Nuclear Medicine/Radiopharmaceuticals Segment by Application 1.3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Comparison by Application (2020-2026) 1.3.2 Oncology 1.3.3 Thyroid 1.3.4 Cardiology 1.4 Nuclear Medicine/Radiopharmaceuticals Market Estimates and Forecasts (2015-2026) 1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2026) 1.4.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2015-2026) 1.4.3 Global Nuclear Medicine/Radiopharmaceuticals Price Trends (2015-2026) 2 Nuclear Medicine/Radiopharmaceuticals Estimate and Forecast by Region 2.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Region: 2015 VS 2020 VS 2026 2.2 Global Nuclear Medicine/Radiopharmaceuticals Retrospective Market Scenario by Region (2015-2020) 2.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2015-2020) 2.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2015-2020) 2.3 Global Nuclear Medicine/Radiopharmaceuticals Market Estimates and Forecasts by Region (2021-2026) 2.3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Estimates and Forecasts by Region (2021-2026) 2.3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Region (2021-2026) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 United States Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2015-2026) 2.4.2 Europe Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2015-2026) 2.4.3 China Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2015-2026) 2.4.4 Japan Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2015-2026) 2.4.5 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2015-2026) 2.4.6 India Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2015-2026) 3 Global Nuclear Medicine/Radiopharmaceuticals Competition Landscape by Players 3.1 Global Top Nuclear Medicine/Radiopharmaceuticals Players by Sales (2015-2020) 3.2 Global Top Nuclear Medicine/Radiopharmaceuticals Players by Revenue (2015-2020) 3.3 Global Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceuticals as of 2019) 3.4 Global Nuclear Medicine/Radiopharmaceuticals Average Price by Company (2015-2020) 3.5 Manufacturers Nuclear Medicine/Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3.7 Primary Interviews with Key Nuclear Medicine/Radiopharmaceuticals Players (Opinion Leaders) 4 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type 4.1 Global Nuclear Medicine/Radiopharmaceuticals Historic Market Review by Type (2015-2020) 4.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020) 4.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2015-2020) 4.1.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Type (2015-2020) 4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Estimates and Forecasts by Type (2021-2026) 4.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2021-2026) 4.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Type (2021-2026) 4.2.3 Global Nuclear Medicine/Radiopharmaceuticals Price Forecast by Type (2021-2026) 5 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application 5.1 Global Nuclear Medicine/Radiopharmaceuticals Historic Market Review by Application (2015-2020) 5.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020) 5.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2015-2020) 5.1.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Application (2015-2020) 5.2 Global Nuclear Medicine/Radiopharmaceuticals Market Estimates and Forecasts by Application (2021-2026) 5.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2021-2026) 5.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Application (2021-2026) 5.2.3 Global Nuclear Medicine/Radiopharmaceuticals Price Forecast by Application (2021-2026) 6 United States Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures 6.1 United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020) 6.2 United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020) 6.3 United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020) 7 Europe Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures 7.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020) 7.2 Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020) 7.3 Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020) 8 China Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures 8.1 China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020) 8.2 China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020) 8.3 China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020) 9 Japan Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures 9.1 Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (3015-3030) 9.2 Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020) 9.3 Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020) 10 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures 10.1 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020) 10.2 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020) 10.3 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020) 11 India Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures 11.1 India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020) 11.2 India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020) 11.3 India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020) 12 Company Profiles and Key Figures in Nuclear Medicine/Radiopharmaceuticals Business 12.1 China Isotope & Radiation 12.1.1 China Isotope & Radiation Corporation Information 12.1.2 China Isotope & Radiation Business Overview 12.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.1.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Products Offered 12.1.5 China Isotope & Radiation Recent Development 12.2 Dongcheng 12.2.1 Dongcheng Corporation Information 12.2.2 Dongcheng Business Overview 12.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Dongcheng Nuclear Medicine/Radiopharmaceuticals Products Offered 12.2.5 Dongcheng Recent Development 12.3 Jaco 12.3.1 Jaco Corporation Information 12.3.2 Jaco Business Overview 12.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Jaco Nuclear Medicine/Radiopharmaceuticals Products Offered 12.3.5 Jaco Recent Development 12.4 Ciaeriar 12.4.1 Ciaeriar Corporation Information 12.4.2 Ciaeriar Business Overview 12.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Products Offered 12.4.5 Ciaeriar Recent Development 12.5 Advanced Molecular-imaging Solution 12.5.1 Advanced Molecular-imaging Solution Corporation Information 12.5.2 Advanced Molecular-imaging Solution Business Overview 12.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Products Offered 12.5.5 Advanced Molecular-imaging Solution Recent Development 12.6 Shanghai Atom Kexing 12.6.1 Shanghai Atom Kexing Corporation Information 12.6.2 Shanghai Atom Kexing Business Overview 12.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Products Offered 12.6.5 Shanghai Atom Kexing Recent Development ... 13 Nuclear Medicine/Radiopharmaceuticals Manufacturing Cost Analysis 13.1 Nuclear Medicine/Radiopharmaceuticals Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals 13.4 Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Nuclear Medicine/Radiopharmaceuticals Distributors List 14.3 Nuclear Medicine/Radiopharmaceuticals Customers 15 Market Dynamics 15.1 Nuclear Medicine/Radiopharmaceuticals Market Trends 15.2 Nuclear Medicine/Radiopharmaceuticals Opportunities and Drivers 15.3 Nuclear Medicine/Radiopharmaceuticals Market Challenges 15.4 Nuclear Medicine/Radiopharmaceuticals Market Restraints 15.5 Porter's Five Forces Analysis 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million) Table 2. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Comparison by Application (2020-2026) (US$ Million) Table 3. Global Market Nuclear Medicine/Radiopharmaceuticals Market Size (US$ Million) by Region:2015 VS 2020 &2026 Table 4. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Region (2015-2020) Table 5. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2015-2020) Table 6. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Market Share by Region (2015-2020)) Table 7. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Region (2015-2020) Table 8. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Forecast by Region (2021-2026) Table 9. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Region (2021-2026) Table 10. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Forecast by Region (2021-2026) Table 11. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share Forecast by Region (2021-2026) Table 12. Global Nuclear Medicine/Radiopharmaceuticals (K Units) of Key Companies (2015-2020) Table 13. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Company (2015-2020) Table 14. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) by Company (2015-2020) Table 15. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Company (2015-2020) Table 16. Global Nuclear Medicine/Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceuticals as of 2019) Table 17. Global Nuclear Medicine/Radiopharmaceuticals Average Price (USD/Unit) of Key Company (2015-2020) Table 18. Manufacturers Nuclear Medicine/Radiopharmaceuticals Manufacturing Sites and Area Served Table 19. Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Main Points Interviewed from Key Nuclear Medicine/Radiopharmaceuticals Players Table 22. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020) Table 23. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2015-2020) Table 24. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2015-2020) Table 25. Global Nuclear Medicine/Radiopharmaceuticals Price (K Units) by Type (2015-2020) Table 26. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2021-2026) Table 27. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2021-2026) Table 28. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2021-2026) Table 29. Global Nuclear Medicine/Radiopharmaceuticals Price (K Units) by Type (2021-2026) Table 30. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2015-2020) Table 31. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2015-2020) Table 32. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2015-2020) Table 33. Global Nuclear Medicine/Radiopharmaceuticals Price (K Units) by Application (2015-2020) Table 34. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2021-2026) Table 35. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2021-2026) Table 36. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2021-2026) Table 37. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Application (2021-2026) Table 38. Global Nuclear Medicine/Radiopharmaceuticals Price (K Units) by Application (2021-2026) Table 39. United States Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Company (2015-2020) Table 40. United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020) Table 41. United States Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020) Table 42. United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020) Table 43. United States Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2015-2020) Table 44. United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020) Table 45. Europe Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Company (2015-2020) Table 46. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020) Table 47. Europe Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020) Table 48. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020) Table 49. Europe Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2015-2020) Table 50. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020) Table 51. China Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Company (2015-2020) Table 52. China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020) Table 53. China Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020) Table 54. China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020) Table 55. China Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2015-2020) Table 56. China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020) Table 57. Japan Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Company (2015-2020) Table 58. Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020) Table 59. Japan Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020) Table 60. Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020) Table 61. Japan Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2015-2020) Table 62. Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020) Table 63. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Company (2015-2020) Table 64. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020) Table 65. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020) Table 66. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020) Table 67. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020) Table 68. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020) Table 69. India Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Company (2015-2020) Table 70. India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020) Table 71. India Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020) Table 72. India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020) Table 73. India Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2015-2020) Table 74. India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020) Table 75. China Isotope & Radiation Corporation Information Table 76. China Isotope & Radiation Description and Business Overview Table 77. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 78. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product Table 79. China Isotope & Radiation Recent Development Table 80. Dongcheng Corporation Information Table 81. Dongcheng Description and Business Overview Table 82. Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 83. Dongcheng Nuclear Medicine/Radiopharmaceuticals Product Table 84. Dongcheng Recent Development Table 85. Jaco Corporation Information Table 86. Jaco Description and Business Overview Table 87. Jaco Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 88. Jaco Nuclear Medicine/Radiopharmaceuticals Product Table 89. Jaco Recent Development Table 90. Ciaeriar Corporation Information Table 91. Ciaeriar Description and Business Overview Table 92. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 93. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product Table 94. Ciaeriar Recent Development Table 95. Advanced Molecular-imaging Solution Corporation Information Table 96. Advanced Molecular-imaging Solution Description and Business Overview Table 97. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 98. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product Table 99. Advanced Molecular-imaging Solution Recent Development Table 100. Shanghai Atom Kexing Corporation Information Table 101. Shanghai Atom Kexing Description and Business Overview Table 102. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 103. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product Table 104. Shanghai Atom Kexing Recent Development Table 105. Production Base and Market Concentration Rate of Raw Material Table 106. Key Suppliers of Raw Materials Table 107. Nuclear Medicine/Radiopharmaceuticals Distributors List Table 108. Nuclear Medicine/Radiopharmaceuticals Customers List Table 109. Nuclear Medicine/Radiopharmaceuticals Market Key Trends Table 110. Nuclear Medicine/Radiopharmaceuticals Key Opportunities and Drivers Table 111. Nuclear Medicine/Radiopharmaceuticals Market Challenges Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Nuclear Medicine/Radiopharmaceuticals Product Picture Figure 2. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2020 & 2026 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2020 & 2026 Figure 6. Oncology Examples Figure 7. Thyroid Examples Figure 8. Cardiology Examples Figure 9. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Growth Rate (2015-2026) Figure 10. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Growth Rate (2015-2026) Figure 11. Global Nuclear Medicine/Radiopharmaceuticals Price Trends Growth Rate (2015-2026) (USD/Unit) Figure 12. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region: 2015 VS 2020 Figure 13. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region: 2021 VS 2026 Figure 14. United States Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026) Figure 15. United States Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Growth Rate (2015-2026) Figure 16. Europe Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026) Figure 17. Europe Nuclear Medicine/Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026) Figure 18. China Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026) Figure 19. China Nuclear Medicine/Radiopharmaceuticals Sales (Million USD) and Growth Rate (2015-2026) Figure 20. Japan Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026) Figure 21. Japan Nuclear Medicine/Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026) Figure 22. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026) Figure 23. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026) Figure 24. India Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026) Figure 25. India Nuclear Medicine/Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026) Figure 26. Global 5 Largest Nuclear Medicine/Radiopharmaceuticals Players Market Share by Revenue in Nuclear Medicine/Radiopharmaceuticals 2015 & 2019 Figure 27. Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 28. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2015-2020) Figure 29. Global Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate by Type in 2015 & 2019 Figure 30. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Application (2015-2020) Figure 31. Global Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate by Application in 2015 & 2019 Figure 32. United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019 Figure 33. United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019 Figure 34. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2019 Figure 35. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019 Figure 36. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2019 Figure 37. China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2019 Figure 38. China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019 Figure 39. China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2019 Figure 40. Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2019 Figure 41. Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019 Figure 42. Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2019 Figure 43. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2019 Figure 44. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019 Figure 45. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2019 Figure 46. India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2019 Figure 47. India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019 Figure 48. India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2019 Figure 49. Key Raw Materials Price Trend Figure 50. Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceuticals Figure 51. Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals Figure 52. Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Porter's Five Forces Analysis Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

China Isotope & Radiation Dongcheng Jaco Ciaeriar Advanced Molecular-imaging Solution Shanghai Atom Kexing